Tuberculostatic activity of 2-pyridyl-(4)-1,3,4-oxdiazolon-(5), its p-amino-salicylate and other related substances

Brodhage, H; Smith, Alison K.

doi:10.1016/s0366-0869(55)80047-0

Cited by 4 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The purely biochemical explanation of the above may be that the pyridyl-oxadiazolone and its analogues block the enzyme system responsible fo r the metabolic degradation of isoniazid or other tuberculostatic. In the course of the past three years we have had occasion to extend our observations to other oxadiazolones: p-amino o-hydroxy-phenyl-I, 3, shows, as already pointed out, about the satne tuberculostatic activity as p-amino-salicylic acid and 80-go per cent cross resistance with it. The oxadiazolone is much more slowly eliminated by the human than PAS.…”

supporting

confidence: 59%

Metabolic Pathway and its Relationship to the Biological Activity of some Tuberculostatic and Leprostatic Agents

Smith¹

1964

Leprosy Review

View full text Add to dashboard Cite

It is generally agreed that the metabolic pathway of a drug and its thera peutic activity are relatcd1 2. Some years ag03 metabolic studi e s on the two tuberculostatics 4-pyridyl-oxadiazolone5 and isoniazid, showed that both substances gave in the rat three identical metabolites. This fact was considered sufficient evidence to draw the conc1usion that 4-pyridyl oxadiazolone was metabolised in the body via isoniazid, which latter would be responsible for the tuberculostasis. The two drugs would be therefore clinically identical. Cross resistance studies using the two sub stances against various strains of Mycobacterium tuberculosis showed between 80-90 per cent cross resistance, confirming this view. Studies on 4-pyridyl oxadiazolone5 were therefore stopped, it being considered that it was simply another somewhat less active form of isoniazid. It is proposed here to describe one or two surprises we have experienced in research in the above field in the past few years. I.If one subcultures H37 Rv in the presence ofjust sub-liminal doses of isoniazid, resistance develops rapidly as shown in Table I. After six sub cultures the minimal inhibitory dose of isoniazid has risen from I : 40 million to I : 80 thousand.But if 4-pyridyl-oxadiazolone is cultured under the same conditions against H37 Rv resistance emergence is much slower (Table I). 2.It seemed, therefore, that the two substances INH and 4-pyridyl oxadiazolone were not absolutely biologically identical, at least in vitro, otherwise the resistance emergence rates would have been identical too.If their biological spectra are not absolutely identical, it was thought likely that, in the presence of 4-pyridyl-oxadiazolone, the resistance emergence rate towards INH would be modified. If the two substances possess exactly the same biological spectrum, a I : I mixture of INH and 4-pyridyl-oxadiazolone should show a resistance emergence rate'

show abstract

supporting

confidence: 59%

Metabolic Pathway and its Relationship to the Biological Activity of some Tuberculostatic and Leprostatic Agents

Smith¹

1964

Leprosy Review

View full text Add to dashboard Cite

show abstract

“…variants it was observed after 18 sub-cultures that resistance of the tested strain H 37 Rv to 'Vadri ne' had in no way increased (Brodhage and Wilder Smith, 1955;Brodhage, 1955). This fa ct, coupled with the slight toxicity, seemed sufficient justification to test the effect of 'Vadrine' on leprosy.…”

mentioning

confidence: 99%

Vadrine' (S. 131) Assessed Bacteriologically in the Treatment of Experimental Murine Leprosy

Brodhage¹

1958

Leprosy Review

View full text Add to dashboard Cite

Biochemie des Isoniazids

Krüger-Thiemer¹

1957

Jahresbericht Borstel

View full text Add to dashboard Cite

Tuberculostatic activity of 2-pyridyl-(4)-1,3,4-oxdiazolon-(5), its p-amino-salicylate and other related substances

Cited by 4 publications

References 12 publications

Metabolic Pathway and its Relationship to the Biological Activity of some Tuberculostatic and Leprostatic Agents

Metabolic Pathway and its Relationship to the Biological Activity of some Tuberculostatic and Leprostatic Agents

Vadrine' (S. 131) Assessed Bacteriologically in the Treatment of Experimental Murine Leprosy

Biochemie des Isoniazids

Contact Info

Product

Resources

About